These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

409 related articles for article (PubMed ID: 32144488)

  • 1. Glucose transporters in the kidney in health and disease.
    Vallon V
    Pflugers Arch; 2020 Sep; 472(9):1345-1370. PubMed ID: 32144488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal Tubular Handling of Glucose and Fructose in Health and Disease.
    Vallon V; Nakagawa T
    Compr Physiol; 2021 Dec; 12(1):2995-3044. PubMed ID: 34964123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Role of the kidneys in glucose homeostasis. Implication of sodium-glucose cotransporter 2 (SGLT2) in diabetes mellitus treatment].
    Girard J
    Nephrol Ther; 2017 Apr; 13 Suppl 1():S35-S41. PubMed ID: 28577741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting renal glucose reabsorption to treat hyperglycaemia: the pleiotropic effects of SGLT2 inhibition.
    Vallon V; Thomson SC
    Diabetologia; 2017 Feb; 60(2):215-225. PubMed ID: 27878313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The tubular hypothesis of nephron filtration and diabetic kidney disease.
    Vallon V; Thomson SC
    Nat Rev Nephrol; 2020 Jun; 16(6):317-336. PubMed ID: 32152499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experimental type II diabetes and related models of impaired glucose metabolism differentially regulate glucose transporters at the proximal tubule brush border membrane.
    Chichger H; Cleasby ME; Srai SK; Unwin RJ; Debnam ES; Marks J
    Exp Physiol; 2016 Jun; 101(6):731-42. PubMed ID: 27164183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Contribution of the kidney to glucose homeostasis].
    Segura J; Ruilope LM
    Med Clin (Barc); 2013 Sep; 141 Suppl 2():26-30. PubMed ID: 24444521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene deletion of the Na
    Nespoux J; Patel R; Hudkins KL; Huang W; Freeman B; Kim YC; Koepsell H; Alpers CE; Vallon V
    Am J Physiol Renal Physiol; 2019 Jun; 316(6):F1201-F1210. PubMed ID: 30995111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Probing SGLT2 as a therapeutic target for diabetes: basic physiology and consequences.
    Gallo LA; Wright EM; Vallon V
    Diab Vasc Dis Res; 2015 Mar; 12(2):78-89. PubMed ID: 25616707
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increase in SGLT1-mediated transport explains renal glucose reabsorption during genetic and pharmacological SGLT2 inhibition in euglycemia.
    Rieg T; Masuda T; Gerasimova M; Mayoux E; Platt K; Powell DR; Thomson SC; Koepsell H; Vallon V
    Am J Physiol Renal Physiol; 2014 Jan; 306(2):F188-93. PubMed ID: 24226519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Physiology of renal glucose handling via SGLT1, SGLT2 and GLUT2.
    Ghezzi C; Loo DDF; Wright EM
    Diabetologia; 2018 Oct; 61(10):2087-2097. PubMed ID: 30132032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of SGLT1 and SGLT2 inhibitors.
    Rieg T; Vallon V
    Diabetologia; 2018 Oct; 61(10):2079-2086. PubMed ID: 30132033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene knockout of the Na
    Nespoux J; Patel R; Zhang H; Huang W; Freeman B; Sanders PW; Kim YC; Vallon V
    Am J Physiol Renal Physiol; 2020 May; 318(5):F1100-F1112. PubMed ID: 32116018
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Approaching to DM2 through sodium-glucose cotransporter-2: does it make sense?
    Segura J
    Med Clin (Barc); 2016 Nov; 147 Suppl 1():22-25. PubMed ID: 28760221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SGLT2 inhibition and renal urate excretion: role of luminal glucose, GLUT9, and URAT1.
    Novikov A; Fu Y; Huang W; Freeman B; Patel R; van Ginkel C; Koepsell H; Busslinger M; Onishi A; Nespoux J; Vallon V
    Am J Physiol Renal Physiol; 2019 Jan; 316(1):F173-F185. PubMed ID: 30427222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Knockout of Na
    Song P; Huang W; Onishi A; Patel R; Kim YC; van Ginkel C; Fu Y; Freeman B; Koepsell H; Thomson S; Liu R; Vallon V
    Am J Physiol Renal Physiol; 2019 Jul; 317(1):F207-F217. PubMed ID: 31091127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The mechanisms and therapeutic potential of SGLT2 inhibitors in diabetes mellitus.
    Vallon V
    Annu Rev Med; 2015; 66():255-70. PubMed ID: 25341005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dapagliflozin Binds Specifically to Sodium-Glucose Cotransporter 2 in the Proximal Renal Tubule.
    Ghezzi C; Yu AS; Hirayama BA; Kepe V; Liu J; Scafoglio C; Powell DR; Huang SC; Satyamurthy N; Barrio JR; Wright EM
    J Am Soc Nephrol; 2017 Mar; 28(3):802-810. PubMed ID: 27620988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms of Protective Effects of SGLT2 Inhibitors in Cardiovascular Disease and Renal Dysfunction.
    Liu B; Wang Y; Zhang Y; Yan B
    Curr Top Med Chem; 2019; 19(20):1818-1849. PubMed ID: 31456521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal effects of SGLT2 inhibitors in cardiovascular patients with and without chronic kidney disease: focus on heart failure and renal outcomes.
    Gronda EG; Vanoli E; Iacoviello M; Urbinati S; Caldarola P; Colivicchi F; Gabrielli D
    Heart Fail Rev; 2023 May; 28(3):723-732. PubMed ID: 35098383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.